Introducing AuroraCell’s

“Innate Immunotherapy”

The pioneering innate immunotherapy technique is in the early pre clinical proof of concept stage. We are optimistic that as the research progresses we will be able to translate the technology into a life saving treatment for patients with liver cirrhosis and there is potential that the application can extend beyond to other diseases demonstrating potentially massive scalability and meaning the scope of people we could help in the future is even bigger.

  • It all begins with an idea, a passion to make a difference in the world. This lead to the launch of a business.

  • AuroraCell is taking the idea from concept to reality

  • Join us on the journey to bring a new breakthrough treatment to market

Our Research

Innovation with Purpose

Unique Cellular Therapy

Translational Medicine

Patient Focused

As AuroraCell’s research advances we will translate the technology from pre-clinical phase research to clinical phase research in order to bring a safe effective and revolutionary treatment for liver disease to market. Liver disease mortality has quadrupled in the last 50 years (British Liver Trust). When end stage or decompensated cirrhosis is reached the only treatment is transplant for which there are strict criteria and almost 1 in 6 people die while waiting for a donor organ. This is the unmet need and the niche in which AuroraCell’s solution strives to make a difference.

If you have any questions please get in touch.